SCIENTIFIC PROGRAM
08.00 - 18.00 Registration
08. 30 – 08.45 Welcome to NefroCarDia – Official opening
Onco – Nephrology session
08.45 – 10.30 Session I Chair: Andreea Andronesi
08.45 - 09.10 Further on Onco-Nephrology - Do We Need a Nephrologist to Optimize the Oncologic Patient's Outcome? - Oana Schiller, Timișoara (Ro)
09.10 - 9.35 Sequencing of treatment lines in metastatic renal cancer (clear cell) - Sorin Săftescu, Timișoara (Ro)
09.35 - 09.55 Diagnosis of renal tumors - urological approach - Răzvan Bardan, Timișoara (Ro)
09.55 - 10.20 Acute kidney injury in acute leukemia - the role of renal biopsy - Andreea Andronesi, Bucharest (Ro)
10-20 - 10.30 Discussions
10.30 - 11.00 Coffee break
11.00 - 13.00 Session II Chair: Flaviu Bob
11.00 - 11.25 Individualized nutrition in cancer patients with multiple comorbidities – Ioana Haș, Oradea (Ro)
11.25 - 11.50 Difficulties in the management of a case of bronchopulmonary neoplasm complicated with psoriatic arthropathy - from oncologist to rheumatologist - case presentation - Elena Sîrbu, Mihaela Pașca-Feneșan - Timișoara (Ro)
11.50 - 12.15 Use of contrast agents in the imaging diagnosis of tumors – indications, contraindications and pharmacovigilance - Diana Manolescu, Amalia Constantinescu, Timișoara (Ro)
12.15 - 12.30 Severe hypokalemia - a paraneoplasic (almost renal) case - Andreea Gostian, Timișoara (Ro)
12.30 - 12.45 One resilient kidney in a case of infectious and oncological medical storm - Laura-Maria Caian, Timișoara (Ro)
12.45 - 12.55 Discussions
13.00 - 14.00 Lunch break
14.00 - 16.15 Session I Chairs: Romulus Timar, Flaviu Bob
14.00 - 14.30 The cardio renal liver metabolic syndrome: the need for a multidisciplinary approach
- Adina Braha, Laura Gaiță, Romulus Timar, Timișoara (Ro)
14.30 - 14.55 Do we need tubular biomarkers in CKD? - Flaviu Bob, Timișoara (Ro)
14.55 - 15.20 Kidney damage, obesity and insulin resistance - interrelationships and therapeutic perspectives - Delia Reurean-Pintilei, Iași (Ro)
15.20 - 15.45 Cardiovascular and metabolic complications after transplantation - Austin Chukwu Chukwuma, Liverpool (UK)
15.45 - 16.10 Prediabetes - the first step in prevention - Anca Pantea-Stoian, Bucharest (Ro)
16.10 - 16.15 Discussions
16.45 – 18.40 Session II Chairs: Ina Kacso, Bogdan Timar
16.45 - 17.10 The future in the treatment of diabetes - Bogdan Timar, Timișoara (Ro)
17.10 – 17.35 Anticoagulation in atrial fibrillation in dialysis patients - Ina Kacso, Timișoara (Ro)
17.40 - 18.40 Astra-Zeneca Symposium
Dapagliflozin - the foundation of protective treatment in CardioRenoMetabolic disorders
Renal Impairment - Major Impact on the Evolution of CardioRenoMetabolic Disorders, Adalbert Schiller, Timișoara (Ro)
Dapa - therapeutic intervention for survival in heart failure, Daniel Lighezan, Timișoara (Ro)
Benefits of Dapa from prevention to improved survival of patients with type 2 diabetes mellitus and CardioRenal involvement, Romulus Timar, Timișoara (Ro)
18.40 - 19.40 Servier Symposium
Hypertension and dyslipidemia – risk factors in the cardiovascular continuum
Flaviu Bob, Timișoara
Milena Slovenski, Timișoara
Bogdan Timar, Timișoara
19.40 – 20.00 Sanofi Symposium
Early diagnosis, basis of therapeutic results in Fabry disease – Adina Ionac, Timișoara
20.30 Dinner
FRIDAY, NOVEMBER 22 :
08.15 - 10.20 Session I Chairs: Liliana Tuță, Natalia Pătrașcu
08.15 - 08.40 Visceral adiposity, between the obesity paradox and normal weight paradigm, in CKD patients - Liliana-Ana Tuță, Alina-Mihaela Stăniguț, Camelia Pană
08.40 – 09.05 Metabolic syndrome, fertility and pregnancy. Cardiologist's perspective - Natalia Pătrașcu, Bucharest (Ro)
09.05 – 09.30 Acute kidney injury in pregnancy - Adalbert Schiller, Timișoara (Ro)
09.30 – 09.50 The evolution of obstetric management from “third trimester disgravidia' to “hypertensive disorders associated with pregnancy” – Manuela Neagu, Bucharest (Ro)
09.50 - 10.10 Neonatal composite outcome after maternal renal injury - Flavia Chișavu, Timișoara (Ro)
10.10 - 10.20 Discussions
10.20 - 10.50 Coffee break
10.50 – 12.40 Session II Chairs: Adrian Covic, Adalbert Schiller
10.50 - 11.15 Updates 2024 in the treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) - Adrian Covic, Iași (Ro)
11.15 – 11.40 Resistant hypertension and challenges with advancing chronic kidney disease - Rajkumar Chinnadurai, Manchester (UK)
11.40 - 12.05 What does early treatment mean in chronic kidney disease? - Adalbert Schiller, Timișoara (Ro)
12.05 - 12.30 The kidney - is it a victim or a target in the HFrEF 4 pillars treatment - Adelina Mihăescu, Timișoara (Ro)
12.30 – 12.40 - Discussions
12.40 - 13.10 BBraun Symposium
Truth or dare in kidney disease, Oana Schiller, Timișoara (Ro)
13.10 - 14.00 Lunch break
14.00 - 14.45 Boehringer Symposium
The Empower Program - the kidney in the spotlight
Chair: Adalbert Schiller, Timișoara (Ro)
Adrian Covic, Iași (Ro), Ina Kacso, Cluj-Napoca (Ro)
14.45 – 16.00 Session III Chairs: Ovidiu Bedreag, Oana Schiller
14.45 – 15.10 When do we initiate and how do we choose renal replacement therapy in intensive care? - Ovidiu Bedreag, Timișoara (Ro)
15.10 – 15.35 Rare causes of acute kidney injury in intensive care – can we rely on biomarkers?! - Oana Schiller, Timișoara
15.35 – 15.55 Decongestive therapy in cardiac failure - Roxana Buzaş, Timisoara
15.55 – 16.00 Discussions
16.00 - 16.30 Sanofi Symposium
Challenges in the diagnosis and treatment of Fabry disease, Ligia Petrica, Timișoara
16.30 - 17.00 Coffee break
17.00 - 19.50 Session IV Chairs: Adalbert Schiller, Ionuț Nistor
17.00 - 17.25 Glomerulonephritis and recurrent glomerulonephritis in our transplant population - Austin Chuckwuma, Liverpool (UK)
17.25 - 17.50 Therapeutic particularities in dialysis patients with cardiovascular pathology - Viviana Ivan, Timișoara
17.50 - 18.15 Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes - Ionuț Nistor, Iași (Ro)
18.15 – 18.40 Protein-restricted diets supplemented with Ketoanalogues in Chronic Kidney Disease - myth or reality?! - Liliana Gârneață, Bucharest (Ro)
18.40 – 19.05 Drug-induced neurotoxicity in chronic kidney disease patients - Flori Gădălean, Timișoara (Ro)
19.05 – 19.20 Indications for renal biopsy in diabetic kidney disease – insights from a case report - Felix Mărălescu, Timișoara (Ro)
19.20 - 19.40 Pacemaker carrier for complete heart block in a patient on permanent catheter dialysis – Carina Bogdan, Oana Sandu, Adrian Apostol, Timișoara (Ro)
19.40 - 19.50 Discussions
20.30 Dinner
SATURDAY, NOVEMBER 23:
08.30 - 10.35 Session I Chairs: Ligia Petrica, Gener Ismail
08.30 - 08.55 SGLT2i beyond metabolic, cardio-, and renal protection. Neuroprotection - a new challenge - Ligia Petrica, Timișoara (Ro)
08.55 - 09.20 - From pathogenesis to therapeutic approach in proliferative lupus nephritis: the role of B lymphocyte and complement system - Gener Ismail, București (Ro)
09.20 - 09.45 Long term outcomes in a large single centre transplant cohort : viral infections, graft loss and survival - Philip Kalra, Manchester (UK)
09.45 - 10.10 Polycystic ovary syndrome - a cardiometabolic paradox? - Dana Stoian, Andreea Bena, Luciana Moisa Luca, Timișoara (Ro)
10.10 - 10.30 Rare systemic complications of vascular access in dialysis - Iulia Grosu, Timișoara (Ro)
10.30 - 10.35 Discussions
Targeted treatment in IgA nephropathy – Kinpeygo works when and where it matters
Adalbert Schiller, Timișoara
Gener Ismail, București
11.05 - 11.30 Coffee break
11.30 - 12.15 Boehringer Symposium
An arc over time: 10 years of Empagliflozin benefits
Chair: Gener Ismail, București (Ro)
Romulus Timar, Timișoara (Ro)
Viviana Ivan, Timișoara (Ro)
Adelina Mihăescu, Timișoara (Ro)
12.15 - 13.40 Session II Chairs: Liana Gheorghe, Roxana Șirli
12.15 - 12.40 Integrated approach to the patient with MASLD- Liana Gheorghe, Bucharest (Ro)
12.40 - 13.05 Non-invasive evaluation of liver damage in metabolic syndrome - Roxana Șirli, Timișoara (Ro)
13.05 - 13.25 Impact of MASLD on renal function: exploring the link with Chronic Kidney Disease - Luciana Marc, Timișoara (Ro)
13.25 - 13.35 Discussions
13.35 - 14.30 Lunch break
14.30 - 14.50 CSL Vifor Symposium
Management of hyperphosphatemia: advances and challenges in Sucroferric Oxyhydroxide Treatment in Dialysis Patients, Ramona Stroescu, Timișoara
14.50 - 17.30 Session III Chairs: Adalbert Schiller, Philip Kalra
14.50 - 15.10 Optimal management of severe cardio-renal failure : an interactive case-based discussion - Philip Kalra, Manchester (UK)
15.10 - 16.25 Case presentations
15.10 – 15.25 Between the treatment of hyperkalemia and the insertion of a pacemaker – how we choose?! - Alexandru Pescariu, Timișoara (Ro)
15.25 – 15. 40 Percutaneous revascularization for bilateral renal artery disease in a patient with severe renovascular hypertension - Vladiana Romina Turi, Timișoara (Ro)
15.40 – 15.55 Cardio-renal impairment in systemic amyloidosis – from diagnosis to management - Mihaela Pătruica, Timișoara (Ro)
15.55 – 16.10 Rhabdomyolysis and acute kidney injury – the importance of early diagnosis - Iulia Oprea, Timișoara (Ro)
16.10 – 16.25 Cardio-renal syndrome, a cardiologist's perspective: what do we protect first, the heart or the kidneys? - Vlad Meche, Timisoara (Ro)
16.25 - 16.50 Artificial Intelligence in Cardio-Renal-Metabolic research: progress and potential - Benjamin James, Manchester (UK)
16.50 - 17.15 Acidosis in chronic kidney disease – a neglected risk factor?! - Lazăr Chișavu, Timișoara
17.15 - 17.30 Do we need interdisciplinary communication?! – what messages do we take home from NefroCarDia 2024?! - Adalbert Schiller, Oana Schiller, Timișoara (Ro)
17.30 Closing remarks